Assessing fibromyalgia-related fatigue: Content validity and psychometric performance of the Fatigue Visual Analogue Scale in adult patients with fibromyalgia

B. K. Crawford, E. C. Piault, C. Lai, Robert (Rob) Bennett

    Research output: Contribution to journalArticle

    15 Citations (Scopus)

    Abstract

    Objectives: To document 1) the content validity and 2) measure improvements in fatigue, using the Fatigue Visual Analogue Scale (VAS) assessment tool in patients with fibromyalgia. Methods: The relevance and comprehensiveness of the Fatigue VAS were tested through a qualitative analysis of 20 subjects' verbatim transcripts from semi-structured qualitative interviews. Data from two randomised, controlled trials in fibromyalgia (n=1121) were used to conduct correlation analyses with the Fatigue and Tiredness items from the Fibromyalgia Impact Questionnaire (FIQ) and the Short Form-36 Vitality scale. Known-groups and cross classification analyses were conducted to demonstrate the ability to measure improvement in fatigue using the Fatigue VAS. Results: All subjects spontaneously reported that fatigue was an important symptom to capture in fibromyalgia. The Fatigue VAS was well understood by most subjects (n=18/20). High correlations (Pearson r>0.75) and good agreement (k>0.66) were found between the Fatigue VAS and the FIQ tiredness items no. 16 and 17 and SF-36 Vitality scale. In both clinical trials there was a substantial separation of approximately 20 points on the mean change in the Fatigue VAS score between responders (>30% improvement in pain VAS) and non-responders. Conclusion: Previous studies have confirmed that fatigue is a major component of the fibromyalgia experience. This current study reports that fibromyalgia patients spontaneously rated fatigue as a highly significant feature of their illness, and supports the use of the Fatigue VAS as a valid questionnaire in fibromyalgia clinical trials.

    Original languageEnglish (US)
    JournalClinical and Experimental Rheumatology
    Volume29
    Issue number6 SUPPL. 69
    StatePublished - 2011

    Fingerprint

    Fibromyalgia
    Visual Analog Scale
    Psychometrics
    Fatigue
    Clinical Trials
    Aptitude
    Pain Measurement
    Randomized Controlled Trials

    Keywords

    • Fatigue
    • Fibromyalgia
    • Outcome assessment (health care)

    ASJC Scopus subject areas

    • Rheumatology
    • Immunology
    • Immunology and Allergy

    Cite this

    Assessing fibromyalgia-related fatigue : Content validity and psychometric performance of the Fatigue Visual Analogue Scale in adult patients with fibromyalgia. / Crawford, B. K.; Piault, E. C.; Lai, C.; Bennett, Robert (Rob).

    In: Clinical and Experimental Rheumatology, Vol. 29, No. 6 SUPPL. 69, 2011.

    Research output: Contribution to journalArticle

    @article{869b19d9c6d147ccabef69d939c38392,
    title = "Assessing fibromyalgia-related fatigue: Content validity and psychometric performance of the Fatigue Visual Analogue Scale in adult patients with fibromyalgia",
    abstract = "Objectives: To document 1) the content validity and 2) measure improvements in fatigue, using the Fatigue Visual Analogue Scale (VAS) assessment tool in patients with fibromyalgia. Methods: The relevance and comprehensiveness of the Fatigue VAS were tested through a qualitative analysis of 20 subjects' verbatim transcripts from semi-structured qualitative interviews. Data from two randomised, controlled trials in fibromyalgia (n=1121) were used to conduct correlation analyses with the Fatigue and Tiredness items from the Fibromyalgia Impact Questionnaire (FIQ) and the Short Form-36 Vitality scale. Known-groups and cross classification analyses were conducted to demonstrate the ability to measure improvement in fatigue using the Fatigue VAS. Results: All subjects spontaneously reported that fatigue was an important symptom to capture in fibromyalgia. The Fatigue VAS was well understood by most subjects (n=18/20). High correlations (Pearson r>0.75) and good agreement (k>0.66) were found between the Fatigue VAS and the FIQ tiredness items no. 16 and 17 and SF-36 ™ Vitality scale. In both clinical trials there was a substantial separation of approximately 20 points on the mean change in the Fatigue VAS score between responders (>30{\%} improvement in pain VAS) and non-responders. Conclusion: Previous studies have confirmed that fatigue is a major component of the fibromyalgia experience. This current study reports that fibromyalgia patients spontaneously rated fatigue as a highly significant feature of their illness, and supports the use of the Fatigue VAS as a valid questionnaire in fibromyalgia clinical trials.",
    keywords = "Fatigue, Fibromyalgia, Outcome assessment (health care)",
    author = "Crawford, {B. K.} and Piault, {E. C.} and C. Lai and Bennett, {Robert (Rob)}",
    year = "2011",
    language = "English (US)",
    volume = "29",
    journal = "Clinical and Experimental Rheumatology",
    issn = "0392-856X",
    publisher = "Clinical and Experimental Rheumatology S.A.S.",
    number = "6 SUPPL. 69",

    }

    TY - JOUR

    T1 - Assessing fibromyalgia-related fatigue

    T2 - Content validity and psychometric performance of the Fatigue Visual Analogue Scale in adult patients with fibromyalgia

    AU - Crawford, B. K.

    AU - Piault, E. C.

    AU - Lai, C.

    AU - Bennett, Robert (Rob)

    PY - 2011

    Y1 - 2011

    N2 - Objectives: To document 1) the content validity and 2) measure improvements in fatigue, using the Fatigue Visual Analogue Scale (VAS) assessment tool in patients with fibromyalgia. Methods: The relevance and comprehensiveness of the Fatigue VAS were tested through a qualitative analysis of 20 subjects' verbatim transcripts from semi-structured qualitative interviews. Data from two randomised, controlled trials in fibromyalgia (n=1121) were used to conduct correlation analyses with the Fatigue and Tiredness items from the Fibromyalgia Impact Questionnaire (FIQ) and the Short Form-36 Vitality scale. Known-groups and cross classification analyses were conducted to demonstrate the ability to measure improvement in fatigue using the Fatigue VAS. Results: All subjects spontaneously reported that fatigue was an important symptom to capture in fibromyalgia. The Fatigue VAS was well understood by most subjects (n=18/20). High correlations (Pearson r>0.75) and good agreement (k>0.66) were found between the Fatigue VAS and the FIQ tiredness items no. 16 and 17 and SF-36 ™ Vitality scale. In both clinical trials there was a substantial separation of approximately 20 points on the mean change in the Fatigue VAS score between responders (>30% improvement in pain VAS) and non-responders. Conclusion: Previous studies have confirmed that fatigue is a major component of the fibromyalgia experience. This current study reports that fibromyalgia patients spontaneously rated fatigue as a highly significant feature of their illness, and supports the use of the Fatigue VAS as a valid questionnaire in fibromyalgia clinical trials.

    AB - Objectives: To document 1) the content validity and 2) measure improvements in fatigue, using the Fatigue Visual Analogue Scale (VAS) assessment tool in patients with fibromyalgia. Methods: The relevance and comprehensiveness of the Fatigue VAS were tested through a qualitative analysis of 20 subjects' verbatim transcripts from semi-structured qualitative interviews. Data from two randomised, controlled trials in fibromyalgia (n=1121) were used to conduct correlation analyses with the Fatigue and Tiredness items from the Fibromyalgia Impact Questionnaire (FIQ) and the Short Form-36 Vitality scale. Known-groups and cross classification analyses were conducted to demonstrate the ability to measure improvement in fatigue using the Fatigue VAS. Results: All subjects spontaneously reported that fatigue was an important symptom to capture in fibromyalgia. The Fatigue VAS was well understood by most subjects (n=18/20). High correlations (Pearson r>0.75) and good agreement (k>0.66) were found between the Fatigue VAS and the FIQ tiredness items no. 16 and 17 and SF-36 ™ Vitality scale. In both clinical trials there was a substantial separation of approximately 20 points on the mean change in the Fatigue VAS score between responders (>30% improvement in pain VAS) and non-responders. Conclusion: Previous studies have confirmed that fatigue is a major component of the fibromyalgia experience. This current study reports that fibromyalgia patients spontaneously rated fatigue as a highly significant feature of their illness, and supports the use of the Fatigue VAS as a valid questionnaire in fibromyalgia clinical trials.

    KW - Fatigue

    KW - Fibromyalgia

    KW - Outcome assessment (health care)

    UR - http://www.scopus.com/inward/record.url?scp=84858842876&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84858842876&partnerID=8YFLogxK

    M3 - Article

    C2 - 21813054

    AN - SCOPUS:84858842876

    VL - 29

    JO - Clinical and Experimental Rheumatology

    JF - Clinical and Experimental Rheumatology

    SN - 0392-856X

    IS - 6 SUPPL. 69

    ER -